Analysis of first recurrence and survival in patients with stage i non-small cell lung cancer treated with surgical resection or stereotactic radiation therapy

Journal of Thoracic and Cardiovascular Surgery

Volumn 147, Issue 4, 2014, Pages

  Crabtree, Traves D ^a   Puri, Varun ^a   Robinson, Clifford ^a   Bradley, Jeffrey ^a   Broderick, Stephen ^a   Patterson, G Alexander ^a   Liu, Jingxia ^a   Musick, Joanne F ^a   Bell, Jennifer M ^a   Yang, Michael ^a   Meyers, Bryan F ^a  

^a WASHINGTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; COMORBIDITY; DISEASE FREE SURVIVAL; EARLY CANCER; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; LOCAL RECURRENCE FREE SURVIVAL; LUNG FUNCTION; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; RECURRENCE RISK; STEREOTACTIC BODY RADIATION THERAPY; TUMOR VOLUME;

AGED; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PNEUMONECTOMY; RADIOSURGERY; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 84896547453     PISSN: 00225223     EISSN: 1097685X     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2013.11.057     Document Type: Article

References (33)

1. J.D Bradley, I. El Naqa, R.E Drzymala, M. Trovo, G. Jones, and M.D. Denning Stereotactic body radiation therapy for early-stage non-small-cell lung cancer: the pattern of failure is distant Int J Radiat Oncol Biol Phys 77 2010 1146 1150
2. F.J. Lagerwaard, N.E. Verstegen, C.J. Haasbeek, B.J. Slotman, M.A. Paul, and E.F. Smit et al. Outcomes of stereotactic ablative radiotherapy in patients with potentially operable stage I non-small cell lung cancer Int J Radiat Oncol Biol Phys 83 2012 348 353
3. H. Onishi, H. Shirato, Y. Nagata, M. Hiraoka, M. Fujino, and K. Gomi et al. Stereotactic body radiotherapy (SBRT) for operable stage I non-small-cell lung cancer: can SBRT be comparable to surgery? Int J Radiat Oncol Biol Phys 81 2011 1352 1358
4. Y. Shibamoto, C. Hashizume, F. Baba, S. Ayakawa, Y. Manabe, and A. Nagai et al. Stereotactic body radiotherapy using a radiobiology-based regimen for stage I nonsmall cell lung cancer: a multicenter study Cancer 118 2012 2078 2084
5. H. Onishi, T. Araki, H. Shirato, Y. Nagata, M. Hiraoka, and K. Gomi et al. Stereotactic hypofractionated high-dose irradiation for stage I nonsmall cell lung carcinoma: clinical outcomes in 245 subjects in a Japanese multiinstitutional study Cancer 101 2004 1623 1631
6. U. Ricardi, A. Filippi, A. Guarneri, F. Giglioli, P. Ciammella, and P. Franco et al. Stereotactic body radiation therapy for early stage non-small cell lung cancer: results of a prospective trial Lung Cancer 68 2010 72 77
7. R. Timmerman, R. Paulus, J. Galvin, J. Michalski, W. Straube, and J. Bradley et al. Stereotactic body radiation therapy for inoperable early stage lung cancer JAMA 303 2010 1070 1076
8. G.E. Darling, M.S. Allen, P.A. Decker, K. Ballman, R.A. Malthaner, and R.I. Inculet et al. Number of lymph nodes harvested from a mediastinal lymphadenectomy: results of the randomized, prospective American College of Surgeons Oncology Group Z0030 trial Chest 139 2011 1124 1129
9. R.J. Ginsberg, and L.V. Rubinstein Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group Ann Thorac Surg 60 1995 615 622 discussion 622-3
10. R.M. Flores, U.N. Ihekweazu, N. Rizk, J. Dycoco, M.S. Bains, and R.J. Downey et al. Patterns of recurrence and incidence of second primary tumors after lobectomy by means of video-assisted thoracoscopic surgery (VATS) versus thoracotomy for lung cancer J Thorac Cardiovasc Surg 141 2011 59 64
11. R.J. McKenna Jr. New approaches to the minimally invasive treatment of lung cancer Cancer J 11 2005 73 76
12. S Paul, N.K. Altorki, S. Sheng, P.C. Lee, D.H. Harpole, and M.W. Onaitis et al. Thoracoscopic lobectomy is associated with lower morbidity than open lobectomy: a propensity-matched analysis from the STS database J Thorac Cardiovasc Surg 139 2010 366 378
13. A.V. Louie, G. Rodrigues, M. Hannouf, G.S. Zaric, D.A. Plama, and J.Q. Cao et al. Stereotactic body radiotherapy versus surgery for medically operable Stage I non-small-cell lung cancer: a Markov model-based decision analysis Int J Radiat Oncol Biol Phys 81 2011 964 973
14. H.C. Fernando, R.J. Landreneau, S.J. Mandrekar, S.L. Hillman, F.C. Nichols, and B. Meyers et al. Thirty- and ninety-day outcomes after sublobar resection with and without brachytherapy for non-small cell lung cancer: results from a multicenter phase III study J Thorac Cardiovasc Surg 142 2011 1143 1151
15. H.C. Fernando, and R. Timmerman American College of Surgeons Oncology Group Z4099/Radiation Therapy Oncology Group 1021: a randomized study of sublobar resection compared with stereotactic body radiotherapy for high-risk stage I non-small cell lung cancer J Thorac Cardiovasc Surg 144 2012 S35 S38
16. T.D. Crabtree, C.E. Denlinger, B.F. Meyers, I. El Naqa, J. Zoole, and A.S. Krupnick et al. Stereotactic body radiation therapy versus surgical resection for stage I non-small cell lung cancer J Thorac Cardiovasc Surg 140 2010 377 386
17. V. Puri, T.D. Crabtree, S. Kymes, M. Gregory, J. Bell, and J.D. Bradley et al. A comparison of surgical intervention and stereotactic body radiation therapy for stage I lung cancer in high-risk patients: a decision analysis J Thorac Cardiovasc Surg 143 2012 428 436
18. C.G. Robinson, I. El Naqa, T. Crabtree, B. Meyers, V. Puri, and J. Zoole et al. Outcomes after stereotactic body radiation therapy (SBRT) or anatomic surgical resection (ASR) for clinical stage I non-small cell lung cancer Int J Radiat Oncol Biol Phys 78 2010 S15
19. Surgery with or without internal radiation therapy compared with stereotactic body radiation therapy in treating patients with high-risk stage I non-small cell lung cancer. Available at: http://clinicaltrials.gov/ct2/show/ NCT01336894?term=Z4099&rank=1. Accessed April 2013.
20. J.R. Olsen, C.G. Robinson, I. El Naqa, K.M. Creach, R.E. Drzymala, and C. Bloch et al. Dose-response for stereotactic body radiotherapy in early-stage non-small-cell lung cancer Int J Radiat Oncol Biol Phys 81 2011 e299 e303
21. H. Onishi, H. Shirato, Y. Nagata, M. Hiraoka, M. Fujino, and K. Gomi et al. Hypofractionated stereotactic radiotherapy (HypoFXSRT) for stage I non-small cell lung cancer: updated results of 257 patients in a Japanese multi-institutional study J Thorac Oncol 2 7 Suppl 3 2007 S94 S100
22. N. Andratschke, F. Zimmermann, E. Boehm, S. Schill, C. Schoenknecht, and R. Thamm et al. Stereotactic radiotherapy of histologically proven inoperable stage I non-small cell lung cancer: patterns of failure Radiother Oncol 101 2011 245 249
23. C.G. Robinson, T.A. DeWees, I. El Naqa, K.M. Creach, J.R. Olsen, and T.D. Crabtree et al. Patterns of failure after stereotactic body radiation therapy or lobar resection for clinical stage I non-small-cell lung cancer J Thorac Oncol 8 2013 192 201
24. N. Martini, M.S. Bains, M.E. Burt, M.F. Zakowski, P. McCormack, and V. Rusch et al. Incidence of local recurrence and second primary tumors in resected stage I lung cancer J Thorac Cardiovasc Surg 109 1995 120 129
25. C.R. Kelsey, L.B. Marks, D. Hollis, J.L. Hubbs, N.E. Ready, and T.A. D'Amico et al. Local recurrence after surgery for early stage lung cancer: an 11-year experience with 975 patients Cancer 115 2009 5218 5227
26. S Senthi, F.J. Lagerwaard, C.J. Haasbeek, B.J. Slotman, and S. Senan Patterns of disease recurrence after stereotactic ablative radiotherapy for early stage non-small-cell lung cancer: a retrospective analysis Lancet Oncol 13 2012 802 809
27. P. Goldstraw, J. Crowley, K. Chansky, D.J. Giroux, P.A. Groome, and R. Rami-Porta et al. The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours J Thorac Oncol 2 2007 706 714
28. R.M. Flores, B.J. Park, J. Dycoco, A. Aronova, Y. Hirth, and N.P. Rizk et al. Lobectomy by video-assisted thoracic surgery (VATS) versus thoracotomy for lung cancer J Thorac Cardiovasc Surg 138 2009 11 18
29. T. Crabtree, V. Puri, R. Timmerman, H. Fernando, J. Bradley, and P.A. Decker et al. Treatment of stage I lung cancer in high-risk and inoperable patients: comparison of prospective clinical trials using stereotactic body radiotherapy (RTOG 0236), sublobar resection (ACOSOG Z4032), and radiofrequency ablation (ACOSOG Z4033) J Thorac Cardiovasc Surg 145 2013 692 699
30. T.A. DeWees, K.M. Creach, J.R. Olsen, J.D. Bradley, and CG. Robinson Defining optimal comorbidity measures for patients with medically inoperable early-stage non-small cell lung cancer (NSCLC) treated with stereotactic body radiation therapy (SBRT) Int J Radiat Oncol Biol Phys 84 2012 S172
31. A. Brunelli, R.G. Berrisford, G. Rocco, and G. Varela The European Thoracic Database project: composite performance score to measure quality of care after major lung resection Eur J Cardiothorac Surg 35 2009 769 774
32. B.D. Kozower, S. Sheng, S.M. O'Brien, M.J. Liptay, C.L. Lau, and D.R. Jones et al. STS database risk models: predictors of mortality and major morbidity for lung cancer resection Ann Thorac Surg 90 2010 875 881 discussion 881-3
33. C.D. Wright, H.A. Gaissert, J.D. Grab, S.M. O'Brien, E.D. Peterson, and M.S. Allen Predictors of prolonged length of stay after lobectomy for lung cancer: a Society of Thoracic Surgeons General Thoracic Surgery Database risk-adjustment model Ann Thorac Surg 85 2008 1857 1865 discussion 1865